- Query in any language with multilingual search
- Access EUR-Lex and EU Commission case law
- See relevant paragraphs highlighted instantly
Similar Documents
Explore similar documents to your case.We Found Similar Cases for You
Case T-709/22: Order of the General Court of 7 November 2024 – Illumina v Commission (Competition – Concentrations – Pharmaceutical industry market – Acquisition by Illumina of sole control of Grail – Decision declaring the concentration incompatible with the internal market and the functioning of the EEA Agreement – Withdrawal of the contested decision – Disappearance of the subject matter of the action – No need to adjudicate)
ECLI:EU:UNKNOWN:62022TB0709
62022TB0709
With us you find everything. Try it now!
I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!
Valentina R., lawyer
Official Journal of the European Union
C series
—
C/2025/71
6.1.2025
(Case T-709/22)
(Competition - Concentrations - Pharmaceutical industry market - Acquisition by Illumina of sole control of Grail - Decision declaring the concentration incompatible with the internal market and the functioning of the EEA Agreement - Withdrawal of the contested decision - Disappearance of the subject matter of the action - No need to adjudicate)
(C/2025/71)
Language of the case: English
Parties
Applicant: Illumina, Inc. (Wilmington, United States) (represented by: F. González Díaz, M. Siragusa, G. Rizza, N. Latronico, A. Magraner Oliver, J. Blanco Carol and T. Verheyden, lawyers, and by D. Beard and J. Holmes, Barristers-at-Law)
Defendant: European Commission (represented by: P. Berghe, A. Boitos, G. Conte and B. Ernst, acting as Agents)
Interveners in support of the applicant: Biocom California (San Diego, United States) (represented by: B. Amory, A.-S. Perraut and E. Barbier de La Serre, lawyers), and Grail LLC (Menlo Park, United States) (represented by: D. Little, Solicitor, and by C. Esteva Mosso, J. Ruiz Calzado, A. Escrigas Cañameras, J.M. Jiménez-Laiglesia Oñate, A. Giraud and S. Troch, lawyers)
Re:
By its action under Article 263 TFEU, the applicant seeks the annulment of Commission Decision C(2022) 6454 final of 6 September 2022 declaring a concentration to be incompatible with the internal market and the functioning of the EEA Agreement, relating to the acquisition by Illumina of sole control of Grail LLC.
Operative part of the order
1.There is no need to adjudicate on the action.
2.The European Commission shall bear its own costs and shall pay those incurred by Illumina, Inc., Biocom California and Grail LLC.
—
Language of the case: English.
ELI: http://data.europa.eu/eli/C/2025/71/oj
ISSN 1977-091X (electronic edition)
—